McCarthy Tétrault assisted Aptose Biosciences Inc. on the matter. On September 6, 2023, Aptose Biosciences Inc. announced the closing of a US$3 million investment in common shares...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault assisted Aptose Biosciences Inc. on the deal. On December 12, 2022, Aptose Biosciences Inc. has entered into an equity distribution agreement with JonesTrading Institutional...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised Aptose Biosciences on the deal. Aptose Biosciences Inc. has entered into an exclusive license agreement with Hanmi Pharmaceutical to develop and commercialize HM43239. Under the...
You must be a Standard 1 Year member to access this content.
